{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@timestamp": "2023-07-13T15:39:43.000043-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Eli Lilly and Company",
                "xocs:funding-agency": "Eli Lilly and Company",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004312",
                "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
            },
            "xocs:funding-addon-generated-timestamp": "2022-11-16T13:12:32.976Z",
            "xocs:funding-text": "This study was funded by Eli Lilly and Company. We thank Junjun Liu from Eli Lilly and Company for interpreting data, writing, providing critical suggestions for improvement, and preparing the first draft and the final revision. We thank Rubing Han and Jin Wang from Eli Lilly and Company for their contributions to the conception and design of the trial.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60082502",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "State Key Laboratory of Oncology in South China"},
                                {"$": "Collaborative Innovation Center for Cancer Medicine"},
                                {"$": "Sun Yat-Sen University Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60082502",
                                "@dptid": "105824598"
                            },
                            "@affiliation-instance-id": "S2468125321003137-18cfeb4a846df97b1107a3ce1f1921e4",
                            "ce:source-text": "Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China",
                            "@dptid": "105824598"
                        },
                        "author": [{
                            "ce:given-name": "Rui-Hua",
                            "preferred-name": {
                                "ce:given-name": "Rui Hua",
                                "ce:initials": "R.H.",
                                "ce:surname": "Xu",
                                "ce:indexed-name": "Xu R.H."
                            },
                            "@author-instance-id": "S2468125321003137-ac22598cc0a37077a649707981f51812",
                            "@seq": "1",
                            "ce:initials": "R.-H.",
                            "@date-locked": "2022-05-11T23:25:59.991",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Xu",
                            "@auid": "8662243500",
                            "ce:indexed-name": "Xu R.-H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60021615",
                            "@country": "chn",
                            "city": "Harbin",
                            "organization": [
                                {"$": "Department of Gastroenterology"},
                                {"$": "Harbin Medical University Cancer Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60021615",
                                "@dptid": "112935996"
                            },
                            "@affiliation-instance-id": "S2468125321003137-27f5a27bce02e3c5c66f86b47183607e",
                            "ce:source-text": "Department of Gastroenterology, Harbin Medical University Cancer Hospital, Harbin, China",
                            "@dptid": "112935996"
                        },
                        "author": [{
                            "ce:given-name": "Yanqiao",
                            "preferred-name": {
                                "ce:given-name": "Yanqiao",
                                "ce:initials": "Y.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang Y."
                            },
                            "@author-instance-id": "S2468125321003137-3d4a221f02623b1782c01fdb76480346",
                            "@seq": "2",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Zhang",
                            "@auid": "36618458900",
                            "ce:indexed-name": "Zhang Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60118427",
                            "@country": "chn",
                            "city": "Hangzhou",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Sir Run Run Shaw Hospital"},
                                {"$": "College of Medicine"},
                                {"$": "Zhejiang University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60118427",
                                    "@dptid": "122946271"
                                },
                                {"@afid": "60003970"},
                                {"@afid": "60029310"}
                            ],
                            "@affiliation-instance-id": "S2468125321003137-7384ab936d47b6d99136a3eebffe76c1",
                            "ce:source-text": "Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China",
                            "@dptid": "122946271"
                        },
                        "author": [{
                            "ce:given-name": "Hongming",
                            "preferred-name": {
                                "ce:given-name": "Hongming",
                                "ce:initials": "H.",
                                "ce:surname": "Pan",
                                "ce:indexed-name": "Pan H."
                            },
                            "@author-instance-id": "S2468125321003137-ad0658540436132f78252751984308a4",
                            "@seq": "3",
                            "ce:initials": "H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Pan",
                            "@auid": "57202595746",
                            "ce:indexed-name": "Pan H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073601",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Jiangsu Cancer Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073601",
                                "@dptid": "104828808"
                            },
                            "@affiliation-instance-id": "S2468125321003137-74038f9cdc02d154cd4b66280f7b9626",
                            "ce:source-text": "Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, China",
                            "@dptid": "104828808"
                        },
                        "author": [{
                            "ce:given-name": "Jifeng",
                            "preferred-name": {
                                "ce:given-name": "Jifeng",
                                "ce:initials": "J.",
                                "ce:surname": "Feng",
                                "ce:indexed-name": "Feng J."
                            },
                            "@author-instance-id": "S2468125321003137-605c01737790d6bb7dfc0e259060df23",
                            "@seq": "4",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Feng",
                            "@auid": "9744825000",
                            "ce:indexed-name": "Feng J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60001193",
                            "@country": "chn",
                            "city": "Wuhan",
                            "organization": [
                                {"$": "Cancer Center"},
                                {"$": "Union Hospital"},
                                {"$": "Tongji Medical College"},
                                {"$": "Huazhong University of Science and Technology"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60001193",
                                    "@dptid": "109521452"
                                },
                                {"@afid": "60025761"},
                                {"@afid": "60121944"}
                            ],
                            "@affiliation-instance-id": "S2468125321003137-3d3607c7a5d18fc3721deb23b9128f34",
                            "ce:source-text": "Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",
                            "@dptid": "109521452"
                        },
                        "author": [{
                            "ce:given-name": "Tao",
                            "preferred-name": {
                                "ce:given-name": "Tao",
                                "ce:initials": "T.",
                                "ce:surname": "Zhang",
                                "ce:indexed-name": "Zhang T."
                            },
                            "@author-instance-id": "S2468125321003137-cfe62f9716c39245ba4c963f78023f5f",
                            "@seq": "5",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Zhang",
                            "@auid": "57211544689",
                            "ce:indexed-name": "Zhang T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60073655",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Fudan University Zhongshan Hospital"},
                                {"$": "Shanghai Medical College"}
                            ],
                            "affiliation-id": {
                                "@afid": "60073655",
                                "@dptid": "114428380"
                            },
                            "@affiliation-instance-id": "S2468125321003137-0c539b3fe8a017191dc41c9a54cc13fa",
                            "ce:source-text": "Department of Medical Oncology, Fudan University Zhongshan Hospital, Shanghai Medical College, Shanghai, China",
                            "@dptid": "114428380"
                        },
                        "author": [{
                            "ce:given-name": "Tianshu",
                            "preferred-name": {
                                "ce:given-name": "Tianshu",
                                "ce:initials": "T.",
                                "ce:surname": "Liu",
                                "ce:indexed-name": "Liu T."
                            },
                            "@author-instance-id": "S2468125321003137-7bf20d2b4ece14fd2e860cab52d55e67",
                            "@seq": "6",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Liu",
                            "@auid": "56148429600",
                            "ce:indexed-name": "Liu T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60102075",
                            "@country": "chn",
                            "city": "Zhengzhou",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "The First Affiliated Hospital of Zhengzhou University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60102075",
                                "@dptid": "112932316"
                            },
                            "@affiliation-instance-id": "S2468125321003137-27b237679bd36b52d5a325f9c4bd9da4",
                            "ce:source-text": "Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China",
                            "@dptid": "112932316"
                        },
                        "author": [{
                            "ce:given-name": "Yanru",
                            "preferred-name": {
                                "ce:given-name": "Yanru",
                                "ce:initials": "Y.",
                                "ce:surname": "Qin",
                                "ce:indexed-name": "Qin Y."
                            },
                            "@author-instance-id": "S2468125321003137-75212074e9c9b69980223094a1003c9f",
                            "@seq": "7",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Qin",
                            "@auid": "57212659887",
                            "ce:indexed-name": "Qin Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60005189",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "Cancer Center of Nanjing Bayi Hospital"},
                                {"$": "Nanjing Chinese Medicine University"}
                            ],
                            "affiliation-id": {"@afid": "60005189"},
                            "@affiliation-instance-id": "S2468125321003137-cb16a6c45aad6b2ff4ad31dcb49e527b",
                            "ce:source-text": "Cancer Center of Nanjing Bayi Hospital, Nanjing Chinese Medicine University, Nanjing, China"
                        },
                        "author": [{
                            "ce:given-name": "Shukui",
                            "preferred-name": {
                                "ce:given-name": "Shukui",
                                "ce:initials": "S.",
                                "ce:surname": "Qin",
                                "ce:indexed-name": "Qin S."
                            },
                            "@author-instance-id": "S2468125321003137-6d6438504897f2b08cce897e76169840",
                            "@seq": "8",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Qin",
                            "@auid": "57217457374",
                            "ce:indexed-name": "Qin S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "address-part": "Changsha",
                            "@afid": "60017060",
                            "@country": "chn",
                            "city": "Hunan",
                            "organization": [
                                {"$": "Gastroenterology and Urology Department"},
                                {"$": "Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine"},
                                {"$": "Central South University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60017060",
                                    "@dptid": "118677101"
                                },
                                {"@afid": "60121894"}
                            ],
                            "@affiliation-instance-id": "S2468125321003137-60a30ccf06324c60dcd0a8beeed9f6b0",
                            "ce:source-text": "Gastroenterology and Urology Department, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China",
                            "@dptid": "118677101"
                        },
                        "author": [
                            {
                                "ce:given-name": "Xianli",
                                "preferred-name": {
                                    "ce:given-name": "Xianli",
                                    "ce:initials": "X.",
                                    "ce:surname": "Yin",
                                    "ce:indexed-name": "Yin X."
                                },
                                "@author-instance-id": "S2468125321003137-77aa722f8bf899f2a8ad172e3718b052",
                                "@seq": "9",
                                "ce:initials": "X.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Yin",
                                "@auid": "56089755800",
                                "ce:indexed-name": "Yin X."
                            },
                            {
                                "ce:given-name": "Nong",
                                "preferred-name": {
                                    "ce:given-name": "Nong",
                                    "ce:initials": "N.",
                                    "ce:surname": "Yang",
                                    "ce:indexed-name": "Yang N."
                                },
                                "@author-instance-id": "S2468125321003137-29b05b2ee4cee3da60fed76fa8bac912",
                                "@seq": "12",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Yang",
                                "@auid": "56410344100",
                                "ce:indexed-name": "Yang N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60033100",
                            "@country": "chn",
                            "city": "Nanjing",
                            "organization": [
                                {"$": "The Comprehensive Cancer Center of Drum Tower Hospital"},
                                {"$": "Clinical Cancer Institute of Nanjing University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60033100"},
                                {"@afid": "60089944"}
                            ],
                            "@affiliation-instance-id": "S2468125321003137-04cfaf95cac261c26b49eec670570074",
                            "ce:source-text": "The Comprehensive Cancer Center of Drum Tower Hospital, Clinical Cancer Institute of Nanjing University, Nanjing, China"
                        },
                        "author": [{
                            "ce:given-name": "Baorui",
                            "preferred-name": {
                                "ce:given-name": "Baorui",
                                "ce:initials": "B.",
                                "ce:surname": "Liu",
                                "ce:indexed-name": "Liu B."
                            },
                            "@author-instance-id": "S2468125321003137-19346acbc6306a28f3b27132101752de",
                            "@seq": "10",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Liu",
                            "@auid": "57329450700",
                            "ce:indexed-name": "Liu B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60017260",
                            "@country": "chn",
                            "city": "Tianjin",
                            "organization": [
                                {"$": "Medical Oncology"},
                                {"$": "Tianjin Cancer Hospital"}
                            ],
                            "affiliation-id": {"@afid": "60017260"},
                            "@affiliation-instance-id": "S2468125321003137-0748766aa5a929679f94c4d35b2c28b1",
                            "ce:source-text": "Medical Oncology, Tianjin Cancer Hospital, Tianjin, China"
                        },
                        "author": [{
                            "ce:given-name": "Yi",
                            "preferred-name": {
                                "ce:given-name": "Yi",
                                "ce:initials": "Y.",
                                "ce:surname": "Ba",
                                "ce:indexed-name": "Ba Y."
                            },
                            "@author-instance-id": "S2468125321003137-7fdb45d8a340003e884fe4214c61fa1b",
                            "@seq": "11",
                            "ce:initials": "Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Ba",
                            "@auid": "57549493800",
                            "ce:indexed-name": "Ba Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60090650",
                            "@country": "mys",
                            "city": "Kuching",
                            "organization": [
                                {"$": "Radiotherapy and Oncology Department"},
                                {"$": "Hospital Umum Sarawak"}
                            ],
                            "affiliation-id": {
                                "@afid": "60090650",
                                "@dptid": "113786423"
                            },
                            "@affiliation-instance-id": "S2468125321003137-49e16d669e5b887b4ee0fa3a50d5604e",
                            "ce:source-text": "Radiotherapy and Oncology Department, Hospital Umum Sarawak, Kuching, Malaysia",
                            "@dptid": "113786423"
                        },
                        "author": [{
                            "ce:given-name": "Pei Jye",
                            "preferred-name": {
                                "ce:given-name": "Pei Jye",
                                "ce:initials": "P.J.",
                                "ce:surname": "Voon",
                                "ce:indexed-name": "Voon P.J."
                            },
                            "@author-instance-id": "S2468125321003137-79b1267c2c27db56ca1fe8feb372c2c6",
                            "@seq": "13",
                            "ce:initials": "P.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Voon",
                            "@auid": "50462645100",
                            "ce:indexed-name": "Voon P.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "107887048"
                            },
                            "@affiliation-instance-id": "S2468125321003137-49bd9e09247ac68c790d16f6ac5d08c8",
                            "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "107887048"
                        },
                        "author": [{
                            "ce:given-name": "Suebpong",
                            "preferred-name": {
                                "ce:given-name": "Suebpong",
                                "ce:initials": "S.",
                                "ce:surname": "Tanasanvimon",
                                "ce:indexed-name": "Tanasanvimon S."
                            },
                            "@author-instance-id": "S2468125321003137-31c60e959885f7b8f5f6be36ed28f9dd",
                            "@seq": "14",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Tanasanvimon",
                            "@auid": "23089332900",
                            "ce:indexed-name": "Tanasanvimon S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60025685",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Lilly China Drug Development and Medical Affairs Center"},
                                {"$": "Eli Lilly and Company"}
                            ],
                            "affiliation-id": {"@afid": "60025685"},
                            "@affiliation-instance-id": "S2468125321003137-20aed376aefd44f180e751e7cdcaa6ce",
                            "ce:source-text": "Lilly China Drug Development and Medical Affairs Center, Eli Lilly and Company, Shanghai, China"
                        },
                        "author": [
                            {
                                "ce:given-name": "Chan",
                                "preferred-name": {
                                    "ce:given-name": "Chan",
                                    "ce:initials": "C.",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou C."
                                },
                                "@author-instance-id": "S2468125321003137-b8f1a9efc37ddcff9b1c505b948d802c",
                                "@seq": "15",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Zhou",
                                "@auid": "57329450800",
                                "ce:indexed-name": "Zhou C."
                            },
                            {
                                "ce:given-name": "Wan Li",
                                "preferred-name": {
                                    "ce:given-name": "Wan Li",
                                    "ce:initials": "W.L.",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang W.L."
                                },
                                "@author-instance-id": "S2468125321003137-1a749762d6016463e5c847e4d3b6cd6e",
                                "@seq": "16",
                                "ce:initials": "W.L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Zhang",
                                "@auid": "57220108831",
                                "ce:indexed-name": "Zhang W.L."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60008510",
                            "@country": "chn",
                            "city": "Beijing",
                            "organization": [
                                {"$": "Department of Gastrointestinal Oncology"},
                                {"$": "Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)"},
                                {"$": "Peking University Cancer Hospital & Institute"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60008510",
                                    "@dptid": "113108856"
                                },
                                {"@afid": "60001604"}
                            ],
                            "@affiliation-instance-id": "S2468125321003137-eaa583d20b0da8b8a7e1332994889b44",
                            "ce:source-text": "Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China",
                            "@dptid": "113108856"
                        },
                        "author": [{
                            "ce:given-name": "Lin",
                            "preferred-name": {
                                "ce:given-name": "Lin",
                                "ce:initials": "L.",
                                "ce:surname": "Shen",
                                "ce:indexed-name": "Shen L."
                            },
                            "@author-instance-id": "S2468125321003137-6a67ba285786c5a7ae5d31175bb1e723",
                            "@seq": "17",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Shen",
                            "@auid": "57215522987",
                            "ce:indexed-name": "Shen L."
                        }]
                    }
                ],
                "citation-title": "Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial",
                "abstracts": "© 2021 Elsevier LtdBackground: In the global phase 3 RAINBOW study, ramucirumab plus paclitaxel significantly improved overall survival compared with placebo plus paclitaxel in patients with advanced gastric or gastro-oesophageal junction (GEJ) adenocarcinoma. RAINBOW-Asia, a bridging study with similar design to RAINBOW, aimed to evaluate the efficacy and safety of ramucirumab plus paclitaxel for advanced gastric or GEJ adenocarcinoma in Asian, predominantly Chinese, patients. Methods: RAINBOW-Asia was a randomised, double-blind, placebo-controlled, phase 3 trial done at 32 centres in China, Malaysia, the Philippines, and Thailand. Adult patients (≥18 years) with metastatic or locally advanced, unresectable gastric or GEJ adenocarcinoma who previously received fluoropyrimidine\u2013platinum-based chemotherapy were randomly assigned with a centralised interactive web response system in a 2:1 ratio to receive ramucirumab 8 mg/kg or placebo intravenously on days 1 and 15 plus paclitaxel 80 mg/m2 intravenously on days 1, 8, and 15 of every 28-day cycle. Randomisation was stratified by Eastern Cooperative Oncology Group performance status and presence of peritoneal metastases. The co-primary endpoints were progression-free survival and overall survival. Efficacy analyses were done in the intention-to-treat population, and safety analysis included patients who received at least one dose of study treatment. This trial is registered with ClinicalTrials.gov, NCT02898077, and has been completed. Findings: Between March 2, 2017, and June 30, 2020, 440 patients were randomly assigned to receive ramucirumab plus paclitaxel (n=294) or placebo plus paclitaxel (n=146). Median progression-free survival was 4·14 months (95% CI 3·71\u20134·30) in the ramucirumab plus paclitaxel group compared with 3·15 months (2·83\u20134·14) in the placebo plus paclitaxel group (hazard ratio [HR] 0·765, 95% CI 0·613\u20130·955, p=0·0184). Median overall survival was 8·71 months (95% CI 7·98\u20139·49) in the ramucirumab plus paclitaxel group and 7·92 months (6·31\u20139·10) in the placebo plus paclitaxel group (HR 0·963, 95% CI 0·771\u20131·203, p=0·7426). The most common grade 3 or worse treatment-emergent adverse events were decreased neutrophil count (159 [54%] of 293 patients in the ramucirumab plus paclitaxel group vs 56 [39%] of 145 in the placebo plus paclitaxel group), decreased white blood cell count (127 [43%] vs 42 [29%]), anaemia (46 [16%] vs 24 [17%]), hypertension (21 [7%] vs nine [6%]), and febrile neutropenia (18 [6%] vs one [<1%]). Interpretation: These findings, along with the results from RAINBOW, support the use of ramucirumab plus paclitaxel as second-line therapy in a predominantly Chinese population with advanced gastric or GEJ adenocarcinoma. Funding: Eli Lilly and Company, USA. Translation: For the Chinese translation of the abstract see Supplementary Materials section.",
                "correspondence": {
                    "affiliation": {
                        "country": "China",
                        "address-part": "No.52 Fucheng Road, Haidian District",
                        "postal-code": "100142",
                        "@country": "chn",
                        "city": "Beijing",
                        "organization": [
                            {"$": "Department of Gastrointestinal Oncology"},
                            {"$": "Peking University Cancer Hospital & Institute"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Lin",
                        "ce:initials": "L.",
                        "ce:degrees": "MD",
                        "ce:surname": "Shen",
                        "ce:indexed-name": "Shen L."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Lancet Gastroenterol. Hepatol.",
                    "website": {"ce:e-address": {
                        "$": "http://www.journals.elsevier.com/the-lancet-gastroenterology-and-hepatology",
                        "@type": "email"
                    }},
                    "@country": "gbr",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "24681253",
                        "@type": "print"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "6",
                            "@issue": "12"
                        },
                        "pagerange": {
                            "@first": "1015",
                            "@last": "1024"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Elsevier Ltd"},
                    "sourcetitle": "The Lancet Gastroenterology and Hepatology",
                    "@srcid": "21100786228",
                    "publicationdate": {
                        "month": "12",
                        "year": "2021",
                        "date-text": "December 2021",
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "26",
                                    "classification-description": "Immunology, Serology and Transplantation"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "48",
                                    "classification-description": "Gastroenterology"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2721"},
                                {"$": "2715"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "675-21-8",
                                    "chemical-name": "fluoropyrimidine"
                                },
                                {
                                    "cas-registry-number": "33069-62-4",
                                    "chemical-name": "paclitaxel"
                                },
                                {
                                    "cas-registry-number": "7440-06-4",
                                    "chemical-name": "platinum"
                                },
                                {
                                    "cas-registry-number": "947687-13-0",
                                    "chemical-name": "ramucirumab"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies, Monoclonal, Humanized"},
                                {"chemical-name": "Antineoplastic Agents, Phytogenic"},
                                {"chemical-name": "Paclitaxel"},
                                {"chemical-name": "Placebos"},
                                {"chemical-name": "ramucirumab"},
                                {"chemical-name": "Vascular Endothelial Growth Factor Receptor-2"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was funded by Eli Lilly and Company. We thank Junjun Liu from Eli Lilly and Company for interpreting data, writing, providing critical suggestions for improvement, and preparing the first draft and the final revision. We thank Rubing Han and Jin Wang from Eli Lilly and Company for their contributions to the conception and design of the trial.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "Publisher",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "19",
                    "@timestamp": "BST 03:09:07",
                    "@year": "2021",
                    "@month": "11"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015523153",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "636347768",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "936704317",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20211047836",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34626550",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2021493106",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20214614475",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20213788675",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021169271",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "85118876411",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85118876411",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "636347768",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "657866409",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S2468125321003137",
                    "ce:ern": "pii:S2468125321003137",
                    "ce:doi": "10.1016/S2468-1253(21)00313-7"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "30",
                "reference": [
                    {
                        "ref-fulltext": "World Health Organization. GLOBOCAN 2020. Cancer fact sheets. Stomach. https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf. (Accessed 12 April 2021)",
                        "@id": "1",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "GLOBOCAN 2020. Cancer fact sheets. Stomach"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118829026",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 12 April 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Health Organization",
                                "ce:indexed-name": "World Health Organization"
                            }}
                        },
                        "ce:source-text": "World Health Organization. GLOBOCAN 2020. Cancer fact sheets. Stomach. https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf (accessed April 12, 2021)."
                    },
                    {
                        "ref-fulltext": "Wang, FH, Zhang, XT, Li, YF, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun 41 (2021), 747\u2013795.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85109265450",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "747",
                                    "@last": "795"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang F.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "X.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li Y.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Commun"
                        },
                        "ce:source-text": "Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun 2021; 41: 747\u2013795."
                    },
                    {
                        "ref-fulltext": "World Health Organization. GLOBOCAN 2020. Population fact sheets. China. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf. (Accessed 12 April 2021)",
                        "@id": "3",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "GLOBOCAN 2020. Population fact sheets. China"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118864573",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 12 April 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Health Organization",
                                "ce:indexed-name": "World Health Organization"
                            }}
                        },
                        "ce:source-text": "World Health Organization. GLOBOCAN 2020. Population fact sheets. China. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf (accessed April 12, 2021)."
                    },
                    {
                        "ref-fulltext": "National Cancer Institute. Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Stomach Cancer. SEER 18 2011\u20132017, All Races, Both Sexes by SEER Summary Stage 2000. https://seer.cancer.gov/statfacts/html/stomach.html. (Accessed 10 August 2021)",
                        "@id": "4",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://seer.cancer.gov/statfacts/html/stomach.html",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Stomach Cancer. SEER 18 2011\u20132017, All Races, Both Sexes by SEER Summary Stage 2000"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118846600",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 10 August 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Cancer Institute",
                                "ce:indexed-name": "National Cancer Institute"
                            }}
                        },
                        "ce:source-text": "National Cancer Institute. Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Stomach Cancer. SEER 18 2011\u20132017, All Races, Both Sexes by SEER Summary Stage 2000. https://seer.cancer.gov/statfacts/html/stomach.html (accessed Aug 10, 2021)."
                    },
                    {
                        "ref-fulltext": "National Comprehensive Cancer Network. Gastric cancer. Version 3. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. (Accessed 22 June 2021)",
                        "@id": "5",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Gastric cancer. Version 3"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85118858542",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 22 June 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Comprehensive Cancer Network",
                                "ce:indexed-name": "National Comprehensive Cancer Network"
                            }}
                        },
                        "ce:source-text": "National Comprehensive Cancer Network. Gastric cancer. Version 3. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (accessed June 22, 2021)."
                    },
                    {
                        "ref-fulltext": "Lee, KW, Maeng, CH, Kim, TY, et al. A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01). Oncologist 24 (2019), 18\u2013e24.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054806347",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "18",
                                    "@last": "e24"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee K.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Maeng",
                                        "ce:indexed-name": "Maeng C.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim T.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Lee KW, Maeng CH, Kim TY, et al. A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01). Oncologist 2019; 24: 18\u2013e24."
                    },
                    {
                        "ref-fulltext": "Satoh, T, Lee, KH, Rha, SY, et al. Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer. Gastric Cancer 18 (2015), 824\u2013832.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84942115572",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "824",
                                    "@last": "832"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Satoh",
                                        "ce:indexed-name": "Satoh T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee K.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Rha",
                                        "ce:indexed-name": "Rha S.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastric Cancer"
                        },
                        "ce:source-text": "Satoh T, Lee KH, Rha SY, et al. Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer. Gastric Cancer 2015; 18: 824\u201332."
                    },
                    {
                        "ref-fulltext": "Wilke, H, Muro, K, Van Cutsem, E, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 15 (2014), 1224\u20131235.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84908139963",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "1224",
                                    "@last": "1235"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wilke",
                                        "ce:indexed-name": "Wilke H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Wilke H, Muro K, Van Cutsem E, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 2014; 15: 1224\u201335."
                    },
                    {
                        "ref-fulltext": "Lu, D, Shen, J, Vil, MD, et al. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity. J Biol Chem 278 (2003), 43496\u201343507.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0242353266",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "278"},
                                "pagerange": {
                                    "@first": "43496",
                                    "@last": "43507"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Shen",
                                        "ce:indexed-name": "Shen J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Vil",
                                        "ce:indexed-name": "Vil M.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Biol Chem"
                        },
                        "ce:source-text": "Lu D, Shen J, Vil MD, et al. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity. J Biol Chem 2003; 278: 43496\u2013507."
                    },
                    {
                        "ref-fulltext": "Zhu, Z, Hattori, K, Zhang, H, et al. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Leukemia 17 (2003), 604\u2013611.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0344839087",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "604",
                                    "@last": "611"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhu",
                                        "ce:indexed-name": "Zhu Z."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Hattori",
                                        "ce:indexed-name": "Hattori K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Zhu Z, Hattori K, Zhang H, et al. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity. Leukemia 2003; 17: 604\u201311."
                    },
                    {
                        "ref-fulltext": "Fuchs, CS, Tomasek, J, Yong, CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 383 (2014), 31\u201339.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84892852372",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "31",
                                    "@last": "39"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fuchs",
                                        "ce:indexed-name": "Fuchs C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tomasek",
                                        "ce:indexed-name": "Tomasek J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Yong",
                                        "ce:indexed-name": "Yong C.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Fuchs CS, Tomasek J, Yong CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet 2014; 383: 31\u201339."
                    },
                    {
                        "ref-fulltext": "Uyama, Y, Shibata, T, Nagai, N, Hanaoka, H, Toyoshima, S, Mori, K, Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan. Clin Pharmacol Ther 78 (2005), 102\u2013113.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "23444432195",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "78"},
                                "pagerange": {
                                    "@first": "102",
                                    "@last": "113"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Uyama",
                                    "ce:indexed-name": "Uyama Y."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Shibata",
                                    "ce:indexed-name": "Shibata T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Nagai",
                                    "ce:indexed-name": "Nagai N."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Hanaoka",
                                    "ce:indexed-name": "Hanaoka H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Toyoshima",
                                    "ce:indexed-name": "Toyoshima S."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Mori",
                                    "ce:indexed-name": "Mori K."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Pharmacol Ther"
                        },
                        "ce:source-text": "Uyama Y, Shibata T, Nagai N, Hanaoka H, Toyoshima S, Mori K. Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan. Clin Pharmacol Ther 2005; 78: 102\u201313."
                    },
                    {
                        "ref-fulltext": "Aaronson, NK, Ahmedzai, S, Bergman, B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365\u2013376.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1993"},
                            "ref-title": {"ref-titletext": "The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0027417437",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "85"},
                                "pagerange": {
                                    "@first": "365",
                                    "@last": "376"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Aaronson",
                                        "ce:indexed-name": "Aaronson N.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahmedzai",
                                        "ce:indexed-name": "Ahmedzai S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Bergman",
                                        "ce:indexed-name": "Bergman B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365\u201376."
                    },
                    {
                        "ref-fulltext": "EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 16 (1990), 199\u2013208.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1990"},
                            "ref-title": {"ref-titletext": "EuroQol\u2014a new facility for the measurement of health-related quality of life"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "0025688231",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "199",
                                    "@last": "208"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "EuroQol Group",
                                "ce:indexed-name": "EuroQol Group"
                            }},
                            "ref-sourcetitle": "Health Policy"
                        },
                        "ce:source-text": "EuroQol Group. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199\u2013208."
                    },
                    {
                        "ref-fulltext": "Liu, GG, Wu, H, Li, M, Gao, C, Luo, N, Chinese time trade-off values for EQ-5D health states. Value Health 17 (2014), 597\u2013604.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Chinese time trade-off values for EQ-5D health states"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84906263409",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "597",
                                    "@last": "604"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu G.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Gao",
                                    "ce:indexed-name": "Gao C."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Luo",
                                    "ce:indexed-name": "Luo N."
                                }
                            ]},
                            "ref-sourcetitle": "Value Health"
                        },
                        "ce:source-text": "Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health 2014; 17: 597\u2013604."
                    },
                    {
                        "ref-fulltext": "Choi, JH, Choi, YW, Kang, SY, et al. Combination versus single-agent as palliative chemotherapy for gastric cancer. BMC Cancer, 20, 2020, 167.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Combination versus single-agent as palliative chemotherapy for gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081027230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {"@first": "167"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Choi",
                                        "ce:indexed-name": "Choi J.H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Choi",
                                        "ce:indexed-name": "Choi Y.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang S.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Choi JH, Choi YW, Kang SY, et al. Combination versus single-agent as palliative chemotherapy for gastric cancer. BMC Cancer 2020; 20: 167."
                    },
                    {
                        "ref-fulltext": "Fuchs, CS, Muro, K, Tomasek, J, et al. Prognostic factor analysis of overall survival in gastric cancer from two phase III studies of second-line ramucirumab (REGARD and RAINBOW) using pooled patient data. J Gastric Cancer 17 (2017), 132\u2013144.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Prognostic factor analysis of overall survival in gastric cancer from two phase III studies of second-line ramucirumab (REGARD and RAINBOW) using pooled patient data"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85022006266",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "132",
                                    "@last": "144"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Fuchs",
                                        "ce:indexed-name": "Fuchs C.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Tomasek",
                                        "ce:indexed-name": "Tomasek J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastric Cancer"
                        },
                        "ce:source-text": "Fuchs CS, Muro K, Tomasek J, et al. Prognostic factor analysis of overall survival in gastric cancer from two phase III studies of second-line ramucirumab (REGARD and RAINBOW) using pooled patient data. J Gastric Cancer 2017; 17: 132\u201344."
                    },
                    {
                        "ref-fulltext": "Xu, J, Bai, Y, Xu, N, et al. Tislelizumab plus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma. Clin Cancer Res 26 (2020), 4542\u20134550.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Tislelizumab plus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85091346866",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "4542",
                                    "@last": "4550"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Bai",
                                        "ce:indexed-name": "Bai Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Xu J, Bai Y, Xu N, et al. Tislelizumab plus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma. Clin Cancer Res 2020; 26: 4542\u201350."
                    },
                    {
                        "ref-fulltext": "Li, J, Qin, S, Xu, J, et al. Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol 34 (2016), 1448\u20131454.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84968894979",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "1448",
                                    "@last": "1454"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Qin",
                                        "ce:indexed-name": "Qin S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Li J, Qin S, Xu J, et al. Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction. J Clin Oncol 2016; 34: 1448\u201354."
                    },
                    {
                        "ref-fulltext": "Zhang, XD, Shu, YQ, Liang, J, et al. Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res 24 (2012), 291\u2013298.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84875424441",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "291",
                                    "@last": "298"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang X.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Shu",
                                        "ce:indexed-name": "Shu Y.Q."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Liang",
                                        "ce:indexed-name": "Liang J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Chin J Cancer Res"
                        },
                        "ce:source-text": "Zhang XD, Shu YQ, Liang J, et al. Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study. Chin J Cancer Res 2012; 24: 291\u201398."
                    },
                    {
                        "ref-fulltext": "Muro, K, Oh, SC, Shimada, Y, et al. Subgroup analysis of east Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer. J Gastroenterol Hepatol 31 (2016), 581\u2013589.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Subgroup analysis of east Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959094187",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "581",
                                    "@last": "589"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Oh",
                                        "ce:indexed-name": "Oh S.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Shimada",
                                        "ce:indexed-name": "Shimada Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Muro K, Oh SC, Shimada Y, et al. Subgroup analysis of east Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer. J Gastroenterol Hepatol 2016; 31: 581\u201389."
                    },
                    {
                        "ref-fulltext": "Ohtsu, A, Shah, MA, Van Cutsem, E, et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29 (2011), 3968\u20133976.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "80053573446",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "3968",
                                    "@last": "3976"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ohtsu",
                                        "ce:indexed-name": "Ohtsu A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah M.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Van Cutsem",
                                        "ce:indexed-name": "Van Cutsem E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Ohtsu A, Shah MA, Van Cutsem E, et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 2011; 29: 3968\u201376."
                    },
                    {
                        "ref-fulltext": "Shitara, K, Muro, K, Shimada, Y, et al. Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer. Gastric Cancer 19 (2016), 927\u2013938.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84945587359",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "927",
                                    "@last": "938"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Muro",
                                        "ce:indexed-name": "Muro K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Shimada",
                                        "ce:indexed-name": "Shimada Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Gastric Cancer"
                        },
                        "ce:source-text": "Shitara K, Muro K, Shimada Y, et al. Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer. Gastric Cancer 2016; 19: 927\u201338."
                    },
                    {
                        "ref-fulltext": "Davidson, M, Chau, I, Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trial. Transl Gastroenterol Hepatol, 1, 2016, 46.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85007247186",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {"@first": "46"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Davidson",
                                    "ce:indexed-name": "Davidson M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Chau",
                                    "ce:indexed-name": "Chau I."
                                }
                            ]},
                            "ref-sourcetitle": "Transl Gastroenterol Hepatol"
                        },
                        "ce:source-text": "Davidson M, Chau I. Variations in outcome for advanced gastric cancer between Japanese and Western patients: a subgroup analysis of the RAINBOW trial. Transl Gastroenterol Hepatol 2016; 1: 46."
                    },
                    {
                        "ref-fulltext": "Korn, EL, Freidlin, B, Abrams, JS, Overall survival as the outcome for randomized clinical trials with effective subsequent therapies. J Clin Oncol 29 (2011), 2439\u20132442.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Overall survival as the outcome for randomized clinical trials with effective subsequent therapies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79959280313",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "2439",
                                    "@last": "2442"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Korn",
                                    "ce:indexed-name": "Korn E.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Freidlin",
                                    "ce:indexed-name": "Freidlin B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Abrams",
                                    "ce:indexed-name": "Abrams J.S."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Korn EL, Freidlin B, Abrams JS. Overall survival as the outcome for randomized clinical trials with effective subsequent therapies. J Clin Oncol 2011; 29: 2439\u201342."
                    },
                    {
                        "ref-fulltext": "Effing, SMA, Gyawali, B, Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: a meta-analysis of randomized controlled trials. EClinicalMedicine, 25, 2020, 100458.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: a meta-analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "100458",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85090031072",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "25"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Effing",
                                    "ce:indexed-name": "Effing S.M.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Gyawali",
                                    "ce:indexed-name": "Gyawali B."
                                }
                            ]},
                            "ref-sourcetitle": "EClinicalMedicine"
                        },
                        "ce:source-text": "Effing SMA, Gyawali B. Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: a meta-analysis of randomized controlled trials. EClinicalMedicine 2020; 25: 100458."
                    },
                    {
                        "ref-fulltext": "Hironaka, S, Zenda, S, Boku, N, Fukutomi, A, Yoshino, T, Onozawa, Y, Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer 9 (2006), 14\u201318.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33645235645",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "14",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Hironaka",
                                    "ce:indexed-name": "Hironaka S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Zenda",
                                    "ce:indexed-name": "Zenda S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Boku",
                                    "ce:indexed-name": "Boku N."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Fukutomi",
                                    "ce:indexed-name": "Fukutomi A."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Yoshino",
                                    "ce:indexed-name": "Yoshino T."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Onozawa",
                                    "ce:indexed-name": "Onozawa Y."
                                }
                            ]},
                            "ref-sourcetitle": "Gastric Cancer"
                        },
                        "ce:source-text": "Hironaka S, Zenda S, Boku N, Fukutomi A, Yoshino T, Onozawa Y. Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer 2006; 9: 14\u201318."
                    },
                    {
                        "ref-fulltext": "Kodera, Y, Ito, S, Mochizuki, Y, et al. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study). Anticancer Res 27 (2007), 2667\u20132671.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "34547742736",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "2667",
                                    "@last": "2671"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Kodera",
                                        "ce:indexed-name": "Kodera Y."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ito",
                                        "ce:indexed-name": "Ito S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Mochizuki",
                                        "ce:indexed-name": "Mochizuki Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Anticancer Res"
                        },
                        "ce:source-text": "Kodera Y, Ito S, Mochizuki Y, et al. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study). Anticancer Res 2007; 27: 2667\u201371."
                    },
                    {
                        "ref-fulltext": "Hironaka, S, Ueda, S, Yasui, H, et al. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial. J Clin Oncol 31 (2013), 4438\u20134444.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib29",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84891372637",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "4438",
                                    "@last": "4444"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hironaka",
                                        "ce:indexed-name": "Hironaka S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ueda",
                                        "ce:indexed-name": "Ueda S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Yasui",
                                        "ce:indexed-name": "Yasui H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Hironaka S, Ueda S, Yasui H, et al. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trial. J Clin Oncol 2013; 31: 4438\u201344."
                    },
                    {
                        "ref-fulltext": "Shitara, K, Matsuo, K, Takahari, D, et al. Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel. Ann Oncol 21 (2010), 2403\u20132409.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib30",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "78649465796",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "2403",
                                    "@last": "2409"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Shitara",
                                        "ce:indexed-name": "Shitara K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsuo",
                                        "ce:indexed-name": "Matsuo K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Takahari",
                                        "ce:indexed-name": "Takahari D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Shitara K, Matsuo K, Takahari D, et al. Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel. Ann Oncol. 2010; 21: 2403\u201309."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Hangzhou",
            "@id": "60118427",
            "affilname": "Sir Run Run Shaw Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118427",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Zhengzhou",
            "@id": "60102075",
            "affilname": "First Affiliated Hospital of Zhengzhou University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60102075",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kuching",
            "@id": "60090650",
            "affilname": "Hospital Umum Sarawak",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60082502",
            "affilname": "Sun Yat-Sen University Cancer Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60073655",
            "affilname": "Zhongshan Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073655",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "60073601",
            "affilname": "Jiangsu Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073601",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "60033100",
            "affilname": "Nanjing University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033100",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Indianapolis",
            "@id": "60025685",
            "affilname": "Eli Lilly and Company",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025685",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Harbin",
            "@id": "60021615",
            "affilname": "Harbin Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021615",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Tianjin",
            "@id": "60017260",
            "affilname": "Tianjin Medical University Cancer Institute &amp; Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Changsha",
            "@id": "60017060",
            "affilname": "Central South University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017060",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008510",
            "affilname": "Beijing Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008510",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Nanjing",
            "@id": "60005189",
            "affilname": "Nanjing University of Traditional Chinese Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005189",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Wuhan",
            "@id": "60001193",
            "affilname": "Tongji Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001193",
            "affiliation-country": "China"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85118876411",
        "dc:description": "Background: In the global phase 3 RAINBOW study, ramucirumab plus paclitaxel significantly improved overall survival compared with placebo plus paclitaxel in patients with advanced gastric or gastro-oesophageal junction (GEJ) adenocarcinoma. RAINBOW-Asia, a bridging study with similar design to RAINBOW, aimed to evaluate the efficacy and safety of ramucirumab plus paclitaxel for advanced gastric or GEJ adenocarcinoma in Asian, predominantly Chinese, patients. Methods: RAINBOW-Asia was a randomised, double-blind, placebo-controlled, phase 3 trial done at 32 centres in China, Malaysia, the Philippines, and Thailand. Adult patients (≥18 years) with metastatic or locally advanced, unresectable gastric or GEJ adenocarcinoma who previously received fluoropyrimidine\u2013platinum-based chemotherapy were randomly assigned with a centralised interactive web response system in a 2:1 ratio to receive ramucirumab 8 mg/kg or placebo intravenously on days 1 and 15 plus paclitaxel 80 mg/m2 intravenously on days 1, 8, and 15 of every 28-day cycle. Randomisation was stratified by Eastern Cooperative Oncology Group performance status and presence of peritoneal metastases. The co-primary endpoints were progression-free survival and overall survival. Efficacy analyses were done in the intention-to-treat population, and safety analysis included patients who received at least one dose of study treatment. This trial is registered with ClinicalTrials.gov, NCT02898077, and has been completed. Findings: Between March 2, 2017, and June 30, 2020, 440 patients were randomly assigned to receive ramucirumab plus paclitaxel (n=294) or placebo plus paclitaxel (n=146). Median progression-free survival was 4·14 months (95% CI 3·71\u20134·30) in the ramucirumab plus paclitaxel group compared with 3·15 months (2·83\u20134·14) in the placebo plus paclitaxel group (hazard ratio [HR] 0·765, 95% CI 0·613\u20130·955, p=0·0184). Median overall survival was 8·71 months (95% CI 7·98\u20139·49) in the ramucirumab plus paclitaxel group and 7·92 months (6·31\u20139·10) in the placebo plus paclitaxel group (HR 0·963, 95% CI 0·771\u20131·203, p=0·7426). The most common grade 3 or worse treatment-emergent adverse events were decreased neutrophil count (159 [54%] of 293 patients in the ramucirumab plus paclitaxel group vs 56 [39%] of 145 in the placebo plus paclitaxel group), decreased white blood cell count (127 [43%] vs 42 [29%]), anaemia (46 [16%] vs 24 [17%]), hypertension (21 [7%] vs nine [6%]), and febrile neutropenia (18 [6%] vs one [<1%]). Interpretation: These findings, along with the results from RAINBOW, support the use of ramucirumab plus paclitaxel as second-line therapy in a predominantly Chinese population with advanced gastric or GEJ adenocarcinoma. Funding: Eli Lilly and Company, USA. Translation: For the Chinese translation of the abstract see Supplementary Materials section.",
        "pubmed-id": "34626550",
        "prism:coverDate": "2021-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85118876411",
        "dc:creator": {"author": [{
            "ce:given-name": "Rui-Hua",
            "preferred-name": {
                "ce:given-name": "Rui Hua",
                "ce:initials": "R.H.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu R.H."
            },
            "@seq": "1",
            "ce:initials": "R.-H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:degrees": "MD",
            "ce:surname": "Xu",
            "@auid": "8662243500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8662243500",
            "ce:indexed-name": "Xu R.-H."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85118876411"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118876411&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85118876411&origin=inward"
            }
        ],
        "source-id": "21100786228",
        "pii": "S2468125321003137",
        "citedby-count": "29",
        "prism:volume": "6",
        "subtype": "ar",
        "dc:title": "Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial",
        "openaccess": "0",
        "prism:issn": "24681253",
        "publishercopyright": "© 2021 Elsevier Ltd",
        "prism:issueIdentifier": "12",
        "subtypeDescription": "Article",
        "prism:publicationName": "The Lancet Gastroenterology and Hepatology",
        "prism:pageRange": "1015-1024",
        "prism:endingPage": "1024",
        "openaccessFlag": "false",
        "prism:doi": "10.1016/S2468-1253(21)00313-7",
        "prism:startingPage": "1015",
        "dc:identifier": "SCOPUS_ID:85118876411",
        "dc:publisher": "Elsevier Ltd"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adenocarcinoma",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Administration, Intravenous",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged, 80 and over",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antibodies, Monoclonal, Humanized",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Agents, Phytogenic",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Combined Chemotherapy Protocols",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Case-Control Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "China",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Double-Blind Method",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Esophageal Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Esophagogastric Junction",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Malaysia",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Paclitaxel",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Philippines",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Placebos",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Progression-Free Survival",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Safety",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Stomach Neoplasms",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Vascular Endothelial Growth Factor Receptor-2",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Rui-Hua",
            "preferred-name": {
                "ce:given-name": "Rui Hua",
                "ce:initials": "R.H.",
                "ce:surname": "Xu",
                "ce:indexed-name": "Xu R.H."
            },
            "@seq": "1",
            "ce:initials": "R.-H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60082502",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082502"
            },
            "ce:degrees": "MD",
            "ce:surname": "Xu",
            "@auid": "8662243500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8662243500",
            "ce:indexed-name": "Xu R.-H."
        },
        {
            "ce:given-name": "Yanqiao",
            "preferred-name": {
                "ce:given-name": "Yanqiao",
                "ce:initials": "Y.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang Y."
            },
            "@seq": "2",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021615",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021615"
            },
            "ce:degrees": "MD",
            "ce:surname": "Zhang",
            "@auid": "36618458900",
            "author-url": "https://api.elsevier.com/content/author/author_id/36618458900",
            "ce:indexed-name": "Zhang Y."
        },
        {
            "ce:given-name": "Hongming",
            "preferred-name": {
                "ce:given-name": "Hongming",
                "ce:initials": "H.",
                "ce:surname": "Pan",
                "ce:indexed-name": "Pan H."
            },
            "@seq": "3",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60118427",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118427"
            },
            "ce:degrees": "MD",
            "ce:surname": "Pan",
            "@auid": "57202595746",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202595746",
            "ce:indexed-name": "Pan H."
        },
        {
            "ce:given-name": "Jifeng",
            "preferred-name": {
                "ce:given-name": "Jifeng",
                "ce:initials": "J.",
                "ce:surname": "Feng",
                "ce:indexed-name": "Feng J."
            },
            "@seq": "4",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073601",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073601"
            },
            "ce:degrees": "MD",
            "ce:surname": "Feng",
            "@auid": "9744825000",
            "author-url": "https://api.elsevier.com/content/author/author_id/9744825000",
            "ce:indexed-name": "Feng J."
        },
        {
            "ce:given-name": "Tao",
            "preferred-name": {
                "ce:given-name": "Tao",
                "ce:initials": "T.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang T."
            },
            "@seq": "5",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60001193",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001193"
            },
            "ce:degrees": "MD",
            "ce:surname": "Zhang",
            "@auid": "57211544689",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211544689",
            "ce:indexed-name": "Zhang T."
        },
        {
            "ce:given-name": "Tianshu",
            "preferred-name": {
                "ce:given-name": "Tianshu",
                "ce:initials": "T.",
                "ce:surname": "Liu",
                "ce:indexed-name": "Liu T."
            },
            "@seq": "6",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60073655",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073655"
            },
            "ce:degrees": "MD",
            "ce:surname": "Liu",
            "@auid": "56148429600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56148429600",
            "ce:indexed-name": "Liu T."
        },
        {
            "ce:given-name": "Yanru",
            "preferred-name": {
                "ce:given-name": "Yanru",
                "ce:initials": "Y.",
                "ce:surname": "Qin",
                "ce:indexed-name": "Qin Y."
            },
            "@seq": "7",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60102075",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60102075"
            },
            "ce:degrees": "MD",
            "ce:surname": "Qin",
            "@auid": "57212659887",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212659887",
            "ce:indexed-name": "Qin Y."
        },
        {
            "ce:given-name": "Shukui",
            "preferred-name": {
                "ce:given-name": "Shukui",
                "ce:initials": "S.",
                "ce:surname": "Qin",
                "ce:indexed-name": "Qin S."
            },
            "@seq": "8",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005189",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005189"
            },
            "ce:degrees": "MD",
            "ce:surname": "Qin",
            "@auid": "57217457374",
            "author-url": "https://api.elsevier.com/content/author/author_id/57217457374",
            "ce:indexed-name": "Qin S."
        },
        {
            "ce:given-name": "Xianli",
            "preferred-name": {
                "ce:given-name": "Xianli",
                "ce:initials": "X.",
                "ce:surname": "Yin",
                "ce:indexed-name": "Yin X."
            },
            "@seq": "9",
            "ce:initials": "X.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017060",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017060"
            },
            "ce:degrees": "MD",
            "ce:surname": "Yin",
            "@auid": "56089755800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56089755800",
            "ce:indexed-name": "Yin X."
        },
        {
            "ce:given-name": "Baorui",
            "preferred-name": {
                "ce:given-name": "Baorui",
                "ce:initials": "B.",
                "ce:surname": "Liu",
                "ce:indexed-name": "Liu B."
            },
            "@seq": "10",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60033100",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033100"
            },
            "ce:degrees": "MD",
            "ce:surname": "Liu",
            "@auid": "57329450700",
            "author-url": "https://api.elsevier.com/content/author/author_id/57329450700",
            "ce:indexed-name": "Liu B."
        },
        {
            "ce:given-name": "Yi",
            "preferred-name": {
                "ce:given-name": "Yi",
                "ce:initials": "Y.",
                "ce:surname": "Ba",
                "ce:indexed-name": "Ba Y."
            },
            "@seq": "11",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017260",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017260"
            },
            "ce:degrees": "MD",
            "ce:surname": "Ba",
            "@auid": "57549493800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57549493800",
            "ce:indexed-name": "Ba Y."
        },
        {
            "ce:given-name": "Nong",
            "preferred-name": {
                "ce:given-name": "Nong",
                "ce:initials": "N.",
                "ce:surname": "Yang",
                "ce:indexed-name": "Yang N."
            },
            "@seq": "12",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017060",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017060"
            },
            "ce:degrees": "MD",
            "ce:surname": "Yang",
            "@auid": "56410344100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56410344100",
            "ce:indexed-name": "Yang N."
        },
        {
            "ce:given-name": "Pei Jye",
            "preferred-name": {
                "ce:given-name": "Pei Jye",
                "ce:initials": "P.J.",
                "ce:surname": "Voon",
                "ce:indexed-name": "Voon P.J."
            },
            "@seq": "13",
            "ce:initials": "P.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60090650",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650"
            },
            "ce:degrees": "MD",
            "ce:surname": "Voon",
            "@auid": "50462645100",
            "author-url": "https://api.elsevier.com/content/author/author_id/50462645100",
            "ce:indexed-name": "Voon P.J."
        },
        {
            "ce:given-name": "Suebpong",
            "preferred-name": {
                "ce:given-name": "Suebpong",
                "ce:initials": "S.",
                "ce:surname": "Tanasanvimon",
                "ce:indexed-name": "Tanasanvimon S."
            },
            "@seq": "14",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD",
            "ce:surname": "Tanasanvimon",
            "@auid": "23089332900",
            "author-url": "https://api.elsevier.com/content/author/author_id/23089332900",
            "ce:indexed-name": "Tanasanvimon S."
        },
        {
            "ce:given-name": "Chan",
            "preferred-name": {
                "ce:given-name": "Chan",
                "ce:initials": "C.",
                "ce:surname": "Zhou",
                "ce:indexed-name": "Zhou C."
            },
            "@seq": "15",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025685",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025685"
            },
            "ce:degrees": "MD",
            "ce:surname": "Zhou",
            "@auid": "57329450800",
            "author-url": "https://api.elsevier.com/content/author/author_id/57329450800",
            "ce:indexed-name": "Zhou C."
        },
        {
            "ce:given-name": "Wan Li",
            "preferred-name": {
                "ce:given-name": "Wan Li",
                "ce:initials": "W.L.",
                "ce:surname": "Zhang",
                "ce:indexed-name": "Zhang W.L."
            },
            "@seq": "16",
            "ce:initials": "W.L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025685",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025685"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Zhang",
            "@auid": "57220108831",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220108831",
            "ce:indexed-name": "Zhang W.L."
        },
        {
            "ce:given-name": "Lin",
            "preferred-name": {
                "ce:given-name": "Lin",
                "ce:initials": "L.",
                "ce:surname": "Shen",
                "ce:indexed-name": "Shen L."
            },
            "@seq": "17",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008510",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008510"
            },
            "ce:degrees": "MD",
            "ce:surname": "Shen",
            "@auid": "57215522987",
            "author-url": "https://api.elsevier.com/content/author/author_id/57215522987",
            "ce:indexed-name": "Shen L."
        }
    ]}
}}